141 related articles for article (PubMed ID: 6247982)
21. Potency ranking of two new topical corticosteroid creams containing 0.1% desonide or 0.05% halometasone utilising the human skin blanching assay.
Meyer E; Smith EW; Haigh JM; Kanfer I
Arzneimittelforschung; 1988 Dec; 38(12):1840-3. PubMed ID: 3245859
[TBL] [Abstract][Full Text] [Related]
22. Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT.
Guichard A; Humbert P; Tissot M; Muret P; Courderot-Masuyer C; Viennet C
Int J Pharm; 2015 Feb; 479(2):422-9. PubMed ID: 25556056
[TBL] [Abstract][Full Text] [Related]
23. Clobetasone butyrate eye drops. Effect on ocular inflammation and intraocular pressure.
Williamson J; Eilon LA; Walker SR
Trans Ophthalmol Soc U K (1962); 1981; 101(1):27-9. PubMed ID: 6764318
[TBL] [Abstract][Full Text] [Related]
24. [Contact dermatitis caused by creams containing clobetasol propionate].
Camarasa JG; Serra-Baldrich E
Med Cutan Ibero Lat Am; 1988; 16(4):328-30. PubMed ID: 3068444
[TBL] [Abstract][Full Text] [Related]
25. Penetration of various corticosteroids through epidermis in vitro.
Ponec M; Polano MK
Arch Dermatol Res; 1979 May; 265(1):101-4. PubMed ID: 475440
[TBL] [Abstract][Full Text] [Related]
26. Allergic contact dermatitis to topical corticosteroids: clobetasol propionate and clobetasone butyrate.
Dooms-Goossens A; Vanhee J; Vanderheyden D; Gevers D; Willems L; Degreef H
Contact Dermatitis; 1983 Nov; 9(6):470-8. PubMed ID: 6653104
[TBL] [Abstract][Full Text] [Related]
27. Prolyl and lysyl hydroxylase activities of human skin fibroblasts: effect of donor age and ascorbate.
Murad S; Sivarajah A; Pinnell SR
J Invest Dermatol; 1980 Nov; 75(5):404-7. PubMed ID: 6253574
[TBL] [Abstract][Full Text] [Related]
28. Clobetasone butyrate and hydrocortisone butyrate in the treatment of eczema: a double-blind comparison.
Lassus A
Curr Med Res Opin; 1979; 6(3):165-7. PubMed ID: 391489
[TBL] [Abstract][Full Text] [Related]
29. Anti-inflammatory steroids and collagen metabolism: glucocorticoid-mediated alterations of prolyl hydroxylase activity and collagen synthesis.
Cutroneo KR; Counts DF
Mol Pharmacol; 1975 Sep; 11(5):632-9. PubMed ID: 170504
[No Abstract] [Full Text] [Related]
30. The dilution of proprietary corticosteroid ointments--an attempt to evaluate relative clinical potencies.
Gibson JR; Darley C; Kirsch J; Saihan EM; Neild VS
Br J Dermatol; 1982 Apr; 106(4):445-7. PubMed ID: 7073968
[TBL] [Abstract][Full Text] [Related]
31. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
Eriksen K
Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
[TBL] [Abstract][Full Text] [Related]
32. Effects of topical glucocorticoid medication on collagen biosynthesis in the dental pulp.
Uitto VJ; Antila R; Ranta R
Acta Odontol Scand; 1975; 33(5):287-98. PubMed ID: 184644
[TBL] [Abstract][Full Text] [Related]
33. The effects on epidermal DNA synthesis of the butyrate esters of clobetasone and clobetasol, and the propionate ester of clobetasol.
Marshall RC; Du Vivier A
Br J Dermatol; 1978 Mar; 98(3):355-9. PubMed ID: 638042
[TBL] [Abstract][Full Text] [Related]
34. Topical clobetasol-17-propionate: review of its clinical efficacy and safety.
Olsen EA; Cornell RC
J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):246-55. PubMed ID: 3528243
[TBL] [Abstract][Full Text] [Related]
35. Topical hydrocortisone, clobetasol propionate, and calcipotriol do not increase photocarcinogenesis induced by simulated solar irradiation in hairless mice.
Lerche CM; Philipsen PA; Poulsen T; Wulf HC
Exp Dermatol; 2010 Nov; 19(11):973-9. PubMed ID: 20113348
[TBL] [Abstract][Full Text] [Related]
36. The chamber vasoconstrictor assay. I. Comparison with occluded and unoccluded tests using four corticosteroids.
Somerma S
Clin Exp Dermatol; 1980 Jun; 5(2):191-6. PubMed ID: 7438514
[No Abstract] [Full Text] [Related]
37. Hypothalamic-pituitary-adrenal function in children with atopic dermatitis treated with clobetasone butyrate and its clinical evaluation.
Boner AL; Richelli C; De Stefano G; Valletta EA; Ferrari S; Mengoni M
Int J Clin Pharmacol Ther Toxicol; 1985 Feb; 23(2):118-20. PubMed ID: 2985514
[TBL] [Abstract][Full Text] [Related]
38. Activity of different desoximetasone preparations compared to other topical corticosteroids in the vasoconstriction assay.
Borelli C; Gassmueller J; Fluhr JW; Nietsch KH; Schinzel S; Korting HC
Skin Pharmacol Physiol; 2008; 21(3):181-7. PubMed ID: 18523415
[TBL] [Abstract][Full Text] [Related]
39. [Clobetasone butyrate, a topical steroid in geriatrics].
Bonavita E; Bassi R; Mengoni M
Clin Ter; 1985 Mar; 112(5):423-8. PubMed ID: 4017467
[No Abstract] [Full Text] [Related]
40. Topical retinoic acid does not alter the vasoconstrictive properties of topical corticosteroids in humans.
Schmied C; Saurat JH
Dermatologica; 1991; 182(2):107-11. PubMed ID: 2050230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
